Aimed Alliance Submits Comment on Senate Finance Drug Pricing RFI
On August 14, Aimed Alliance submitted a comment to the Senate Finance Committee’s Request for…
Browsing: Multimedia
New Analysis Highlights Potential Challenges Under GUARD and GLOBE Models
A new Yale University study raises questions about how the Trump Administration’s proposed Medicare international…
Aimed Alliance Comment on 340B Drug Pricing Integrity and Affordability for Patients Act
On August 27, 2026, Aimed Alliance submitted feedback on Senator Cassidy’s 340B Drug Pricing Integrity…
Aimed Alliance Published New Resources to Empower Patient Engagement in PDABs
Aimed Alliance released three new patient-centered resources as part of its Patients & PDABs: Ensuring…
Senate Committee Advances Bill to Expand Health Data Privacy Protections Beyond HIPAA
On July 30, the Senate Health, Education, Labor, and Pensions (HELP) Committee unanimously approved the…
Aimed Alliance Urges Medicaid Programs to Ensure UM Policies Are Consistent with State Scope-of-Practice Laws
After reviewing state Medicaid formularies and utilization management policies, Aimed Alliance recently sent letters to…
Aimed Alliance Supports West Virginia Bill to Protect Access to Serious Mental Illness Treatments
On August 7, 2026, Aimed Alliance sent the West Virginia House of Delegate a letter…
Aimed Alliance Urges CMS to Protect Patient Access Under Medicare Drug Negotiation Program
On August 13, 2026, Aimed Alliance submitted comments to CMS regarding its proposed rule to…
Researchers Propose Federal Licensure Framework for Autonomous Clinical AI
In a 2026 JAMA article, researchers proposed a federal licensure framework for autonomous clinical artificial…
Aimed Alliance Urges Patient-Centered, Evidence-Based Reviews by Maryland PDAB
Prior to the Board’s July meeting to conduct cost affordability reviews for Farxiga and Jardiance,…